ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	22449200	A2661V	tax	tax	HTLV-1-HIV Coinfection	R S L	View
2	22449200	A7722G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
3	22449200	A8001G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
4	22449200	A8002G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
5	22449200	A8109G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
6	22449200	A8288G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
7	22449200	A8367C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
8	22449200	C7401T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
9	22449200	C7410A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
10	22449200	C7593T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
11	22449200	C7920T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
12	22449200	C7953T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
13	22449200	C7974T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
14	22449200	C7982T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
15	22449200	C8066G	tax	tax	HTLV-1-HIV Coinfection	R S L	View
16	22449200	C8184T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
17	22449200	C8191T	tax	tax	HTLV-1-HIV Coinfection	R S L	View
18	22449200	G7431A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
19	22449200	G7527A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
20	22449200	G8128A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
21	22449200	G8231A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
22	22449200	G8295A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
23	22449200	G8366A	tax	tax	HTLV-1-HIV Coinfection	R S L	View
24	22449200	S2744N	tax	tax	HTLV-1-HIV Coinfection	R S L	View
25	22449200	T7476C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
26	22449200	T7908C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
27	22449200	T7914C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
28	22449200	T7980C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
29	22449200	T8232C	tax	tax	HTLV-1-HIV Coinfection	R S L	View
30	22449200	T8313C	tax	tax	HTLV-1-HIV Coinfection	R S L	View

Contents
Description

The table shows all curated mutation sites of HTLV1 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.